Korean J Physiol Pharmacol.  2019 Sep;23(5):357-366. 10.4196/kjpp.2019.23.5.357.

Identification of phospholipase C β downstream effect on transient receptor potential canonical 1/4, transient receptor potential canonical 1/5 channels

Affiliations
  • 1Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Korea. insuk@snu.ac.kr
  • 2Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195, USA.

Abstract

Gα(q)-coupled receptor stimulation was implied in the activation process of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heterotetrameric channels. The inactivation occurs due to phosphatidylinositol 4,5-biphosphate (PI(4,5)Pâ‚‚) depletion. When PI(4,5)Pâ‚‚ depletion was induced by muscarinic stimulation or inositol polyphosphate 5-phosphatase (Inp54p), however, the inactivation by muscarinic stimulation was greater compared to that by Inp54p. The aim of this study was to investigate the complete inactivation mechanism of the heteromeric channels upon Gα(q)-phospholipase C β (Gα(q)-PLCβ) activation. We evaluated the activity of heteromeric channels with electrophysiological recording in HEK293 cells expressing TRPC channels. TRPC1/4 and TRPC1/5 heteromers undergo further inhibition in PLCβ activation and calcium/protein kinase C (PKC) signaling. Nevertheless, the key factors differ. For TRPC1/4, the inactivation process was facilitated by Ca²âº release from the endoplasmic reticulum, and for TRPC1/5, activation of PKC was concerned mostly. We conclude that the subsequent increase in cytoplasmic Ca²âº due to Ca²âº release from the endoplasmic reticulum and activation of PKC resulted in a second phase of channel inhibition following PI(4,5)Pâ‚‚ depletion.

Keyword

Calcium; GTP-binding proteins; Protein kinase C; Transient receptor potential channels; Type C phospholipases

MeSH Terms

Calcium
Cytoplasm
Endoplasmic Reticulum
GTP-Binding Proteins
HEK293 Cells
Inositol
Phosphatidylinositol 4,5-Diphosphate
Phospholipases*
Phosphotransferases
Protein Kinase C
Transient Receptor Potential Channels
Type C Phospholipases*
Calcium
GTP-Binding Proteins
Inositol
Phosphatidylinositol 4,5-Diphosphate
Phospholipases
Phosphotransferases
Protein Kinase C
Transient Receptor Potential Channels
Type C Phospholipases

Figure

  • Fig. 1 Transient receptor potential canonical (TRPC) 1α/4β, TRPC1α/5 currents inhibition depend on cytosolic calcium level. (A) Catalytic scheme for phosphatidylinositol 4,5-biphosphate (PI(4,5)P2) by Danio rerio voltage-sensitive lipid phosphatase (DrVSP), inositol polyphosphate 5-phosphatase (Inp54) (left) and, the phospholipase C beta (PLCβ) (right) which produces PI(4)P/Pi and diacylglycerol (DAG)/inositol trisphosphate (IP3), respectively. (B, C) Representative currents trace of TRPC1α/4β (B) and TRPC1α/5 (C) stimulated by TG (1 µM). (D) Summary of current densities between basal and thapsigargin (TG) evoked peak in cells co-expressing YFP-TRPC1α with TRPC4β-CFP or CFP-TRPC5. (E–H) Averaged plots of currents at +100 mV every 10 sec upon carbachol (CCh, 100 µM) stimulation from cells co-expressing muscarinic receptor 3 (M3R), YFP-TRPC1α, and TRPC4β-CFP (E, F) or CFP-TRPC5 (G, H). (F) and (H) show the normalized (norm.) currents with internal solution that contains 0 and 5 mM of 1,2-bis-(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid (BAPTA). The pipette solution contained 0, 0.5, and 5 mM of BAPTA, and each trace was normalized; TRPC1/4β (0 mM, n = 4; 0.5 mM, n = 4; 5 mM, n = 4), TRPC1/5 (0 mM, n = 4; 0.5 mM, n = 5; 5 mM, n = 4). Data are presented as mean ± standard error of the mean; n, sample number; n.s., not significant.

  • Fig. 2 Effects of calcium on heterotetrameric channel currents. (A–D) Rapamycin (rapa) (20 nM, 3) and subsequent addition of thapsigargin (1 µM, 4) or ionomycin (1 µM, 4) induced current inactivation in transient receptor potential canonical (TRPC) 1α/4β after Englerin A (EA) (100 nM, 2) stimulation. (A, C) Representative whole-cell currents of HEK293 cells co-expressing TRPC1α/4β, inositol polyphosphate 5-phosphatase (Inp54), Lyn11 (left) and I–V relationship for selected time points of each stimulation (right). (B, D) Summary of current density at +100 mV induced by the stimulations (thapsigargin [TG], n = 5; ionomycin [Iono], n = 4). (E–H) The conditions are largely the same as those in (A–D), but in cells expressing TRPC1α/5, Inp54, and Lyn11 (TG, n = 4; Iono, n = 5). Data are presented as mean ± standard error of the mean; n, sample number; n.s., not significant. *p < 0.05, **p < 0.01.

  • Fig. 3 Involvement of protein kinase C (PKC) on heteromeric channel current inhibition. (A, B) Effect of a PKC inhibitor on transient receptor potential canonical (TRPC) 1α/4β (A) and TRPC1α/5 (B) current desensitization. CFP-tagged TRPC4β or TRPC5 was coexpressed with YFP-TRPC1α, muscarinic receptor 3 (M3R). Channels were stimulated by carbachol (CCh) (100 µM) twice, with or without GF109203X pretreatment. (C) Summary of desensitization ratio in TRPC1α/4β (2 / 1) and TRPC1α/5 (2′ / 1′) with or without PKC inhibitor, GF109203X and chelerythrine. (D) Plots of currents at +100 mV every 10 sec upon CCh (100 µM) stimulation from cells expressing TRPC1α/4β and TRPC1α/4β (T887A). (E) Comparison of the basal and peak current between wild-type and T887A mutant of TRPC1α/4β. (F) Plots of normalized (norm.) currents at +100 mV upon CCh (100 µM) stimulation from cells expressing TRPC1α/4β and TRPC1α/4β (T887A). (G–I) The conditions are largely the same as those in (D–F), but in cells expressing TRPC1α/5 and TRPC1α/5 (T972A) instead. Data are presented as mean ± standard error of the mean; n.s., not significant. *p < 0.05.

  • Fig. 4 Effect of 1-oleoyl-2-acetyl-sn-glycerol (OAG) on heteromeric channel current. (A, B) Rapamycin (rapa) (20 nM, 3) and subsequent addition of OAG (100 µM, 4) induced current inactivation in transient receptor potential canonical (TRPC) 1α/4β after Englerin A (EA) (100 nM, 2) stimulation. (A) Representative whole-cell currents of HEK293 cells co-expressing TRPC1α/4β, inositol polyphosphate 5-phosphatase (Inp54), Lyn11 (left) and current-voltage relationship for selected time points of each stimulation (right). (B) Summary of current density at +100 mV induced by the stimulations (n = 6). (C, D) The conditions are largely the same as those in (A and B), but in the cells expressing TRPC1α/5 instead (n = 5). Data are presented as mean ± standard error of the mean; n.s., not significant. *p < 0.05.

  • Fig. 5 Transient receptor potential canonical (TRPC) 1/4 and TRPC1/5 channel regulation by the Gαq-phospholipase C (PLC) pathway. (A–D) Scheme of the heteromeric TRPC1/4 and TRPC1/5 with Gαq protein coupled receptor (GPCR). Channels and GPCR expressed in plasma membrane. Schematic diagram of each proteins presented as below box (bottom). (A) In the resting state, guanosine diphosphate (GDP)-bound inactive Gαq proteins are preassembled with Gαq-coupled receptors. (B) Upon association of agonist to muscarinic receptor 3 (M3R), activated Gαq releases from receptor and directly binds to active channels (activation state). Also, as a downstream of the Gαq pathway, active PLC hydrolyzes phosphatidylinositol 4,5-biphosphate (PI(4,5)P2). (C) Depletion of the channel-bound PI(4,5)P2 inhibits channel gating (1st inactivation state). (D) Desensitization of TRPC1/4 and TRPC1/5 channels induced by active PKC and high [Ca2+]i from endoplasmic reticulum (ER) calcium release (2nd inactivation).


Cited by  1 articles

Negative self-regulation of transient receptor potential canonical 4 by the specific interaction with phospholipase C-δ1
Juyeon Ko, Jinhyeong Kim, Jongyun Myeong, Misun Kwak, Insuk So
Korean J Physiol Pharmacol. 2023;27(2):187-196.    doi: 10.4196/kjpp.2023.27.2.187.


Reference

1. Thakur DP, Tian JB, Jeon J, Xiong J, Huang Y, Flockerzi V, Zhu MX. Critical roles of Gi/o proteins and phospholipase C-δ1 in the activation of receptor-operated TRPC4 channels. Proc Natl Acad Sci U S A. 2016; 113:1092–1097.
2. Ong HL, de Souza LB, Ambudkar IS. Role of TRPC channels in store-operated calcium entry. Adv Exp Med Biol. 2016; 898:87–109.
Article
3. Kim H, Jeon JP, Hong C, Kim J, Myeong J, Jeon JH, So I. An essential role of PI(4,5)P2 for maintaining the activity of the transient receptor potential canonical (TRPC)4β. Pflugers Arch. 2013; 465:1011–1021.
4. Imai Y, Itsuki K, Okamura Y, Inoue R, Mori MX. A self-limiting regulation of vasoconstrictor-activated TRPC3/C6/C7 channels coupled to PI(4,5)P2-diacylglycerol signalling. J Physiol. 2012; 590:1101–1119.
5. Itsuki K, Imai Y, Hase H, Okamura Y, Inoue R, Mori MX. PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. J Gen Physiol. 2014; 143:183–201.
6. Myeong J, Kwak M, Jeon JP, Hong C, Jeon JH, So I. Close spatio-association of the transient receptor potential canonical 4 (TRPC4) channel with Gαi in TRPC4 activation process. Am J Physiol Cell Physiol. 2015; 308:C879–C889.
Article
7. Zhang X, Mak S, Li L, Parra A, Denlinger B, Belmonte C, Mc-Naughton PA. Direct inhibition of the cold-activated TRPM8 ion channel by Gαq. Nat Cell Biol. 2012; 14:851–858.
8. Jeon JP, Hong C, Park EJ, Jeon JH, Cho NH, Kim IG, Choe H, Muallem S, Kim HJ, So I. Selective Gαi subunits as novel direct activators of transient receptor potential canonical (TRPC)4 and TRPC5 channels. J Biol Chem. 2012; 287:17029–17039.
9. Shen Y, Rampino MA, Carroll RC, Nawy S. G-protein-mediated inhibition of the Trp channel TRPM1 requires the Gβγ dimer. Proc Natl Acad Sci U S A. 2012; 109:8752–8757.
Article
10. Nilius B, Flockerzi V. Mammalian transient receptor potential (TRP) cation channels. Preface. Handb Exp Pharmacol. 2014; 223:v–vi.
11. Myeong J, Ko J, Kwak M, Kim J, Woo J, Ha K, Hong C, Yang D, Kim HJ, Jeon JH, So I. Dual action of the Gαq-PLCβ-PI(4,5)P2 pathway on TRPC1/4 and TRPC1/5 heterotetramers. Sci Rep. 2018; 8:12117.
Article
12. Dietrich A, Fahlbusch M, Gudermann T. Classical transient receptor potential 1 (TRPC1): channel or channel regulator? Cells. 2014; 3:939–962.
Article
13. Tajeddine N, Zanou N, Van Schoor M, Lebacq J, Gailly P. TRPC1: subcellular localization? J Biol Chem. 2010; 285:le1. author reply le2.
Article
14. Myeong J, Ko J, Hong C, Yang D, Lee KP, Jeon JH, So I. The interaction domains of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heteromultimeric channels. Biochem Biophys Res Commun. 2016; 474:476–481.
Article
15. Kinoshita-Kawada M, Tang J, Xiao R, Kaneko S, Foskett JK, Zhu MX. Inhibition of TRPC5 channels by Ca2+-binding protein 1 in Xenopus oocytes. Pflugers Arch. 2005; 450:345–354.
16. Ordaz B, Tang J, Xiao R, Salgado A, Sampieri A, Zhu MX, Vaca L. Calmodulin and calcium interplay in the modulation of TRPC5 channel activity. Identification of a novel C-terminal domain for calcium/calmodulin-mediated facilitation. J Biol Chem. 2005; 280:30788–30796.
17. Blair NT, Kaczmarek JS, Clapham DE. Intracellular calcium strongly potentiates agonist-activated TRPC5 channels. J Gen Physiol. 2009; 133:525–546.
Article
18. Gross SA, Guzmán GA, Wissenbach U, Philipp SE, Zhu MX, Bruns D, Cavalié A. TRPC5 is a Ca2+-activated channel functionally coupled to Ca2+-selective ion channels. J Biol Chem. 2009; 284:34423–34432.
19. Hong C, Seo H, Kwak M, Jeon J, Jang J, Jeong EM, Myeong J, Hwang YJ, Ha K, Kang MJ, Lee KP, Yi EC, Kim IG, Jeon JH, Ryu H, So I. Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease. Brain. 2015; 138(Pt 10):3030–3047.
Article
20. Hong C, Kwak M, Myeong J, Ha K, Wie J, Jeon JH, So I. Extracellular disulfide bridges stabilize TRPC5 dimerization, trafficking, and activity. Pflugers Arch. 2015; 467:703–712.
Article
21. Akbulut Y, Gaunt HJ, Muraki K, Ludlow MJ, Amer MS, Bruns A, Vasudev NS, Radtke L, Willot M, Hahn S, Seitz T, Ziegler S, Christmann M, Beech DJ, Waldmann H. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. Angew Chem Int Ed Engl. 2015; 54:3787–3791.
22. Hossain MI, Iwasaki H, Okochi Y, Chahine M, Higashijima S, Nagayama K, Okamura Y. Enzyme domain affects the movement of the voltage sensor in ascidian and zebrafish voltage-sensing phosphatases. J Biol Chem. 2008; 283:18248–18259.
Article
23. Mitchell CA, Brown S, Campbell JK, Munday AD, Speed CJ. Regulation of second messengers by the inositol polyphosphate 5-phosphatases. Biochem Soc Trans. 1996; 24:994–1000.
Article
24. Zhu MH, Chae M, Kim HJ, Lee YM, Kim MJ, Jin NG, Yang DK, So I, Kim KW. Desensitization of canonical transient receptor potential channel 5 by protein kinase C. Am J Physiol Cell Physiol. 2005; 289:C591–C600.
Article
25. Putyrski M, Schultz C. Switching heterotrimeric G protein subunits with a chemical dimerizer. Chem Biol. 2011; 18:1126–1133.
Article
26. Ko J, Myeong J, Yang D, So I. Calcium permeability of transient receptor potential canonical (TRPC) 4 channels measured by TRPC4-GCaMP6s. Korean J Physiol Pharmacol. 2017; 21:133–140.
Article
27. Storch U, Forst AL, Philipp M, Gudermann T, Mederos y. Transient receptor potential channel 1 (TRPC1) reduces calcium permeability in heteromeric channel complexes. J Biol Chem. 2012; 287:3530–3540.
Article
28. Rohacs T. Regulation of transient receptor potential channels by the phospholipase C pathway. Adv Biol Regul. 2013; 53:341–355.
Article
29. Venkatachalam K, Zheng F, Gill DL. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem. 2003; 278:29031–29040.
Article
30. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 1999; 397:259–263.
Article
31. Storch U, Forst AL, Pardatscher F, Erdogmus S, Philipp M, Gregoritza M, Mederos Y, Gudermann T. Dynamic NHERF interaction with TRPC4/5 proteins is required for channel gating by diacylglycerol. Proc Natl Acad Sci U S A. 2017; 114:E37–E46.
Article
32. Ko J, Myeong J, Shin YC, So I. Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. Sci Rep. 2019; 9:1849.
Article
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr